DepoMed (DEPO) Sell-Off on Horizon News a 'Buying Opportunity'- Janney
Tweet Send to a Friend
Janney Capital analyst Ken Trbovich reiterated a Buy rating and $35 fair value target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


